Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome - PubMed (original) (raw)

Review

Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome

Mak Adam Daulatzai. Neurotox Res. 2013 Aug.

Abstract

A wide range of clinical consequences may be associated with obstructive sleep apnea (OSA) including systemic hypertension, cardiovascular disease, pulmonary hypertension, congestive heart failure, cerebrovascular disease, glucose intolerance, impotence, gastroesophageal reflux, and obesity, to name a few. Despite this, 82 % of men and 93 % of women with OSA remain undiagnosed. OSA affects many body systems, and induces major alterations in metabolic, autonomic, and cerebral functions. Typically, OSA is characterized by recurrent chronic intermittent hypoxia (CIH), hypercapnia, hypoventilation, sleep fragmentation, peripheral and central inflammation, cerebral hypoperfusion, and cerebral glucose hypometabolism. Upregulation of oxidative stress in OSA plays an important pathogenic role in the milieu of hypoxia-induced cerebral and cardiovascular dysfunctions. Strong evidence underscores that cerebral amyloidogenesis and tau phosphorylation--two cardinal features of Alzheimer's disease (AD), are triggered by hypoxia. Mice subjected to hypoxic conditions unambiguously demonstrated upregulation in cerebral amyloid plaque formation and tau phosphorylation, as well as memory deficit. Hypoxia triggers neuronal degeneration and axonal dysfunction in both cortex and brainstem. Consequently, neurocognitive impairment in apneic/hypoxic patients is attributable to a complex interplay between CIH and stimulation of several pathological trajectories. The framework presented here helps delineate the emergence and progression of cognitive decline, and may yield insight into AD neuropathogenesis. The global impact of CIH should provide a strong rationale for treating OSA and snoring clinically, in order to ameliorate neurocognitive impairment in aged/AD patients.

PubMed Disclaimer

Cited by

Improving the predictive value of interventional animal models data.
Zeiss CJ. Zeiss CJ. Drug Discov Today. 2015 Apr;20(4):475-82. doi: 10.1016/j.drudis.2014.10.015. Epub 2014 Nov 4. Drug Discov Today. 2015. PMID: 25448761 Free PMC article. Review.
Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome.
Bu XL, Liu YH, Wang QH, Jiao SS, Zeng F, Yao XQ, Gao D, Chen JC, Wang YJ. Bu XL, et al. Sci Rep. 2015 Sep 9;5:13917. doi: 10.1038/srep13917. Sci Rep. 2015. PMID: 26351108 Free PMC article.
Resting cerebral blood flow alteration in severe obstructive sleep apnoea: an arterial spin labelling perfusion fMRI study.
Nie S, Peng DC, Gong HH, Li HJ, Chen LT, Ye CL. Nie S, et al. Sleep Breath. 2017 May;21(2):487-495. doi: 10.1007/s11325-017-1474-9. Epub 2017 Feb 16. Sleep Breath. 2017. PMID: 28210922
Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway.
Li H, Lv B, Kong L, Xia J, Zhu M, Hu L, Zhen D, Wu Y, Jia X, Zhu S, Cui H. Li H, et al. Int J Mol Med. 2017 Oct;40(4):1125-1133. doi: 10.3892/ijmm.2017.3089. Epub 2017 Aug 3. Int J Mol Med. 2017. PMID: 28791345 Free PMC article.
Sleep Disturbance, Cognitive Decline, and Dementia: A Review.
Wennberg AMV, Wu MN, Rosenberg PB, Spira AP. Wennberg AMV, et al. Semin Neurol. 2017 Aug;37(4):395-406. doi: 10.1055/s-0037-1604351. Epub 2017 Aug 24. Semin Neurol. 2017. PMID: 28837986 Free PMC article. Review.

References

1. J Neurosci Res. 2008 Jun;86(8):1768-80 - PubMed
1. Med Sci Monit. 2005 Mar;11(3):RA70-5 - PubMed
1. Exp Neurol. 2012 Dec;238(2):176-82 - PubMed
1. Sleep. 2010 Feb;33(2):205-10 - PubMed
1. J Appl Physiol (1985). 1993 Jun;74(6):2828-37 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome - PubMed (original) (raw)